- Oral presentation
- Open Access
Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
© Dass et al; licensee BioMed Central Ltd. 2012
- Published: 1 February 2012
- Dilate Cardiomyopathy
- Late Gadolinium Enhancement
- Myocardial Fibrosis
- Remote Myocardium
- British Heart Foundation
T1 relaxation is prolonged in hypertrophic (HCM) and dilated cardiomyopathy (DCM) and reflects myocardial changes prior to presence of LGE or development of hypertrophy in HCM and wall thinning in DCM.
Both HCM and DCM exhibit variable clinical outcomes. Unfortunately, our ability to risk stratify and characterize disease mechanisms in these patients remains poor, and improved biomarkers are needed. Myocardial fibrosis, both focal and diffuse, is a feature of both HCM and DCM and focal myocardial fibrosis, as assessed by LGE, has been recently identified as a predictor of cardiac death in HCM and DCM.
We recently developed a novel method for non-contrast CMR T1 mapping, a recognized marker of increased water content such as in fibrotic tissue. We hypothesized that T1 mapping offers an alternative to late gadolinium enhancement (LGE) techniques, providing additional non- invasive diagnostic information in HCM and DCM.
Sixty one subjects underwent CMR imaging, 3T Siemens Trio,(29 HCM, 18 DCM and 14 normals). Matching short axis slices were acquired for cine, T1 mapping (short modified look locker inversion recovery - ShMOLLI - sequence) and late gadolinium enhancement (LGE) imaging (0.1 mmol/kg). Myocardium was manually contoured on each slice and divided into 6 segments to calculate: mean T1, mean LGE enhancement (segment intensity divided by signal in remote myocardium), end diastolic wall thickness from cine images.
There was a weak, but significant, correlation between mean T1 and LGE (r= 0.32, p< 0.001). T1 values were significantly higher in segments with LGE than in those without (HCM with LGE 1229±42ms vs no LGE 1193±44ms, p<0.05; DCM with LGE 1252±87ms vs no LGE 1213±55ms p<0.05). However, even in segments unaffected by LGE, T1 values were significantly higher than normal (p<0.001).
In HCM and DCM, non-contrast T1 mapping detects underlying disease processes which to some extent reflect the presence of LGE but yields further insights into adverse ventricular remodeling beyond the traditional measures of wall thickness and LGE. Myocardial T1 values are elevated in HCM patients without LVH and in DCM patients pre wall thinning suggesting that absolute T1 mapping may also have applications in the detection of early myocardial disease. Hence, T1 mapping may become an important new tool for diagnosis, therapy monitoring and prognostic assessment in HCM and DCM.
This research was funded by the British heart foundation.
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.